Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2023 to Q4 2025

Type / Class
Equity / *W EXP 12/17/202
Symbol
RVMDW on Nasdaq
Price per share
$0.86
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
8,066,230
Total reported value
$2,455,615
% of total 13F portfolios
0%
Share change
+4,925
Value change
+$3,514
Number of holders
21
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

As of 30 Sep 2025, 21 institutional investors reported holding 8,066,230 shares of Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW).

Institutional Holders of Revolution Medicines, Inc. - *W EXP 12/17/202 (RVMDW) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$49,327 $0.86 0
2025 Q3 8,066,230 $2,455,615 +$3,514 $0.30 21
2025 Q2 8,041,860 $2,116,552 +$143,332 $0.26 21
2025 Q1 7,647,321 $298,455 -$13,607 $0.04 22
2024 Q4 7,607,269 $1,314,887 +$528,254 $0.18 20
2024 Q3 4,670,066 $654,653 -$223,218 $0.14 23
2024 Q2 4,415,864 $449,673 -$2,591 $0.10 15
2024 Q1 6,884,843 $1,210,097 +$360,139 $0.18 23
2023 Q4 4,907,148 $1,621,737 +$1,596,307 $0.33 21